Home › Neuroendocrine Tumors › Washington
Neuroendocrine Tumors clinical trials in Washington, DC
11 studies for Neuroendocrine Tumors are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Georgetown University, Washington D.C.
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
RecruitingPhase 3
- Investigative Site, Bethesda · 7 mi away
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- MedStar Georgetown University Hospital, Washington D.C.
- Children's National Medical Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi away
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi away
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi away
Neuroendocrine Tumors trials in other cities
- Philadelphia, PA11 studies
- Rochester, MN9 studies
- Houston, TX8 studies
- St. Louis, MO7 studies
- Columbus, OH7 studies
- Chicago, IL7 studies
- Detroit, MI7 studies
- Cleveland, OH7 studies
- Salt Lake City, UT7 studies
- Dallas, TX6 studies
- Miami, FL6 studies
- Cedar Rapids, IA6 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.